B. Concernant-la, R. Au-cours-de-la-rectocolite-hémorragique, .. Au-niveau-symptomatique, and .. , 85 a, p.88

I. Partie and M. Prise-en-charge-du-patient-fumeur-atteint-de, 94 I. Les traitements médicamenteux des MICI, p.94

A. Buisson, G. Bommelaer, and L. Peyrin-biroulet, Rectocolite h??morragique??: ??pid??miologie, physiopathologie, diagnostic, histoire naturelle et strat??gie th??rapeutique, EMC - Gastro-ent??rologie, vol.7, issue.4, pp.1-19, 2012.
DOI : 10.1016/S1155-1968(12)43559-3

X. Dray and P. Marteau, Maladie de Crohn et rectocolite hémorragique, Rev Prat, vol.57, issue.20, pp.2305-2315, 2007.

J. Rambaud, Les maladies inflammatoires chroniques de l'intestin, 1998.

C. Gower-rousseau and A. Duhamel, Epidémiologie des maladies inflammatoires chroniques de l'intestin en France: apport du registre EPIMAD, Disponible sur, 2017.

N. Molodecky, I. Soon, D. Rabi, W. Ghali, M. Ferris et al., Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review, Gastroenterology, vol.142, issue.1, pp.46-54, 2012.
DOI : 10.1053/j.gastro.2011.10.001

J. Kirchgesner, M. Lemaitre, A. Rudnichi, A. Racine, M. Zureik et al., Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases, 2009.

E. Louis and P. Marteau, Maladies inflammatoires chroniques de l'intestin. Doin, 2009.

A. Cortot, G. Pineton-de-chambrun, G. Vernier-massouille, B. Vigneron, G. Rousseau et al., Maladies inflammatoires chroniques de l???intestin??: maladies g??n??tiques ou de l???environnement???, Gastroent??rologie Clinique et Biologique, vol.33, issue.8-9, pp.8-9681, 2009.
DOI : 10.1016/j.gcb.2009.07.005

E. Louis, C. Van-kemseke, P. Latour, J. Belaiche, and C. Reenaers, Genetique et environnement dans les maladies inflammatoires chroniques de l'intestin. Rev Médicale Liège Disponible sur, 2268.

P. Desreumaux and . Et-maladie-de-crohn, NOD2/CARD15 et maladie de Crohn, Gastroent??rologie Clinique et Biologique, vol.29, issue.6-7, pp.696-700, 2005.
DOI : 10.1016/S0399-8320(05)82158-X

F. Benkhadra and R. Humbel, Les marqueurs s??rologiques des maladies inflammatoires chroniques intestinales (MICI), Immuno-analyse & Biologie Sp??cialis??e, vol.23, issue.4, pp.202-213, 2008.
DOI : 10.1016/j.immbio.2008.07.007

J. Hugot, J. Cezard, and G. Thomas, Epidémiologie et génétique des maladies inflammatoires chroniques de l'intestin. Presse Médicale, pp.29-33, 1998.

P. Desreumaux, Concepts physiopathologiques des??maladies inflammatoires chroniques de??l'intestin, La Revue de M??decine Interne, vol.27, issue.2, pp.47-55, 2006.
DOI : 10.1016/j.revmed.2006.03.015

C. Felley, Les apports de NOD2/CARD15 dans la prise en charge de la maladie de Crohn, Hépato-Gastro Oncol Dig. 1 nov, vol.13, issue.6, pp.429-461, 2006.

A. Couturier-maillard and M. Chamaillard, Etude des interactions du microbiote intestinal avec le récepteur de l'immunité innée NOD2 dans la maladie de Crohn et le cancer colorectal, Disponible sur, 2016.

J. Lamoril, J. Deybach, and P. Bouizegarène, Maladie de??Crohn et??g??n??tique: connaissances??actuelles, Immuno-analyse & Biologie Sp??cialis??e, vol.22, issue.3, pp.137-50, 2007.
DOI : 10.1016/j.immbio.2007.01.002

P. Dominique, Maladie de Crohn: mieux comprendre la maladie, son diagnostic et ses traitements afin d'en optimiser la prise en charge officinale [Thèse d'exercice], 2012.

P. L. Codogno, autophagie, dégrader plus pour vivre plus? mais attention ! médecine/sciences, avr, vol.25, issue.4, pp.323-327, 2009.

A. Glasser, P. Lapaquette, and A. Darfeuille-michaud, Alt??ration de l???autophagie chez les patients atteints de maladie de Crohn, m??decine/sciences, vol.25, issue.4, pp.349-51, 2009.
DOI : 10.1051/medsci/2009254349

D. Mccole, IBD Candidate Genes and Intestinal Barrier Regulation, Inflammatory Bowel Diseases, vol.20, issue.10, pp.1829-1878, 2014.
DOI : 10.1097/MIB.0000000000000090

P. Jantchou, E. Monnet, and F. Carbonnel, Les facteurs d???environnement dans la maladie de Crohn et la rectocolite h??morragique (tabac et appendicectomie exclus), Gastroent??rologie Clinique et Biologique, vol.30, issue.6-7, pp.859-67, 2008.
DOI : 10.1016/S0399-8320(06)73333-4

K. Dolan and E. Chang, Diet, gut microbes, and the pathogenesis of inflammatory bowel diseases, Molecular Nutrition & Food Research, vol.4, issue.1, 2016.
DOI : 10.1371/journal.pone.0006386

F. Ruemmele, Role of Diet in Inflammatory Bowel Disease, Annals of Nutrition and Metabolism, vol.68, issue.1, pp.33-41, 2016.
DOI : 10.1159/000445392

X. Hebuterne, Quelle place pour les huiles de poisson au cours des maladies inflammatoires chroniques de l'intestin ? Hépato-Gastro Oncol Dig, pp.173-180, 1998.

J. P. Hugot and J. Viala, Physiopathologie de la maladie de Crohn: l'indispensable pour le clinicien

R. Fiasse, O. Dewit, and D. Latinne, Is endemic helminthiasis in sub-Saharan Africa the sole reason for the low prevalence of inflammatory bowel disease? Impacts on public health, Journal Africain d'H??pato-Gastroent??rologie, vol.155, issue.2, pp.58-66, 2009.
DOI : 10.1155/2004/298064

A. Hviid, H. Svanstrom, and M. Frisch, Antibiotic use and inflammatory bowel diseases in childhood, Gut, vol.60, issue.1, pp.49-54, 2011.
DOI : 10.1136/gut.2010.219683

S. Chan and A. Hart, Aspirin use and development of inflammatory bowel disease: confounding or causation? authors??? reply, Alimentary Pharmacology & Therapeutics, vol.42, issue.11-12, pp.1351-1351, 2011.
DOI : 10.1136/gut.42.3.387

B. Thabet, J. Charfi, N. Mnif, L. Yaich, S. Zouari et al., Troubles émotionnels associés aux maladies inflammatoires chroniques de l'intestin. Tunis Médicale, juill, vol.90, issue.7, pp.557-63, 2012.

J. Mawdsley and D. Rampton, The Role of Psychological Stress in Inflammatory Bowel Disease, Neuroimmunomodulation, vol.13, issue.5-6, pp.327-363, 2007.
DOI : 10.1159/000104861

V. Timms, G. Daskalopoulos, H. Mitchell, and B. Neilan, The Association of Mycobacterium avium subsp. paratuberculosis with Inflammatory Bowel Disease, PLOS ONE, vol.3, issue.3???4, p.148731, 2016.
DOI : 10.1371/journal.pone.0148731.s001

A. Racine, M. Boutron, and F. Carbonnel, Les facteurs d'environnement au cours des maladies inflammatoires chroniques de l'intestin. Hépato-Gastro Oncol Dig. 1 mars 2013, pp.175-184

M. Seirafi, S. Cunningham, and A. Hadengue, Le microbiote dans les maladies du foie et du tube digestif : la révolution annoncée. Rev Médicale Suisse, pp.1696-700, 2011.

J. Matricon, Immunopathogen??se des maladies inflammatoires chroniques de l???intestin, m??decine/sciences, vol.26, issue.4, pp.405-415, 2010.
DOI : 10.1051/medsci/2010264405

J. Legendre, Microbiote intestinal et maladies inflammatoires chroniques de l'intestin [Internet]. Toulouse 3, Disponible sur, 2016.

L. Beaugerie and H. Sokol, Collège des universitaires en hépato-gastro-entérologie, éditeurs. Les fondamentaux de la pathologie digestive: enseignement intégré, appareil digestif, 2014.

M. Montbarbon, Régulation de la réponse inflammatoire intestinale par la fumée de cigarette: caractérisation des mécanismes cellulaires et moléculaires chez la souris, Disponible sur, 2016.

P. Seksik, Microbiote intestinal et MICI, Gastroent??rologie Clinique et Biologique, vol.34, issue.4, pp.48-55, 2010.
DOI : 10.1016/S0399-8320(10)70007-5

S. Vindigni, T. Zisman, D. Suskind, and C. Damman, The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions, Therapeutic Advances in Gastroenterology, vol.57, issue.4, pp.606-631, 2016.
DOI : 10.1136/gut.2007.133603

J. Hukkanen, Metabolism and Disposition Kinetics of Nicotine, Pharmacological Reviews, vol.57, issue.1, pp.79-115, 2005.
DOI : 10.1124/pr.57.1.3

I. Berlin, Pathophysiological rational of smoking cessation drug treatments: present and futur developments, Lett Pneumol, vol.11, issue.2, pp.84-93

N. Clere, Pour une ann??e sans tabac, Actualit??s Pharmaceutiques, vol.50, issue.503, pp.33-38, 2011.
DOI : 10.1016/S0515-3700(11)70881-3

C. Chevalier and A. Nguyen, Composition et nocivit?? du tabac, Actualit??s Pharmaceutiques, vol.55, issue.560, pp.22-27, 2016.
DOI : 10.1016/j.actpha.2016.09.005

O. Groupe, OMS sur la réglementation des produits du tabac : rapport sur les bases scientifiques de la réglementation des produits du tabac : quatrième rapport d'un groupe d'étude de l'OMS [Internet]. Organisation mondiale de la Santé, Disponible sur, p.78071, 2016.

P. Guichenez, J. Perriot, P. Dupont, J. Reny, I. Clauzel et al., La conduite du sevrage tabagique, Sang Thromb Vaiss. 1 mars, vol.18, issue.3, pp.136-184, 2006.

G. Lagrue, Traitement de la dépendance tabagique. EMC -Cardiol-Angéiologie, nov, vol.1, issue.4, pp.443-55, 2004.

M. Underner, S. Hadjadj, M. Beauchant, F. Bridoux, F. Debiais et al., Effets du tabagisme sur la thyro??de, le tube digestif, le rein et l???os, Revue des Maladies Respiratoires, vol.25, issue.10, pp.1261-78, 2008.
DOI : 10.1016/S0761-8425(08)75091-5

J. Perriot, . Underner, . Michel, and L. Doly-kuchcik, Tabac : quels risques pour la santé ? Rev Prat, mars, vol.62, pp.333-339, 2012.

J. Trédaniel, F. Savinelli, S. Vignot, G. Bousquet, C. Maignan et al., Conséquences du tabagisme passif chez l'adulte, Rev Mal Respir, vol.23, issue.2, pp.473-80, 2006.

J. Halfvarson, J. T. Magnuson, A. Montgomery, S. Orholm, M. Tysk et al., Environmental factors in inflammatory bowel disease: A co-twin control study of a Swedish-Danish twin population, Inflammatory Bowel Diseases, vol.12, issue.10, pp.925-958, 2006.
DOI : 10.1097/01.mib.0000228998.29466.ac

K. Somerville, R. Logan, M. Edmond, and M. Langman, Smoking and Crohn's disease., BMJ, vol.289, issue.6450, pp.954-960, 1984.
DOI : 10.1136/bmj.289.6450.954

B. Calkins, A meta-analysis of the role of smoking in inflammatory bowel disease, Digestive Diseases and Sciences, vol.284, issue.12, pp.1841-54, 1989.
DOI : 10.1007/BF01536701

S. Mahid, K. Minor, R. Soto, C. Hornung, and S. Galandiuk, Smoking and Inflammatory Bowel Disease: A Meta-analysis, Mayo Clinic Proceedings, vol.81, issue.11, pp.1462-71, 2006.
DOI : 10.4065/81.11.1462

J. Karczewski, B. Poniedzia?ek, P. Rzymski, A. Rychlewska-ha?czewska, Z. Adamski et al., The effect of cigarette smoking on the clinical course of inflammatory bowel disease, Gastroenterology Review, vol.3, pp.153-162, 2014.
DOI : 10.5114/pg.2014.43577

J. Begon, P. Juillerat, J. Cornuz, and C. C. , Tabagisme et système digestif : une relation complexe. Partie 1 : maladies inflammatoires chroniques de l'intestin et consommation de tabac, Rev Med Suisse, vol.11, issue.478, pp.1282-1289, 2015.

M. Underner, J. Perriot, J. Cosnes, P. Beau, G. Peiffer et al., Tabagisme, sevrage tabagique et maladie de Crohn, La Presse M??dicale, vol.45, issue.4, pp.390-402, 2016.
DOI : 10.1016/j.lpm.2016.02.008

URL : https://hal.archives-ouvertes.fr/hal-01302577

J. Niu, J. Miao, Y. Tang, Q. Nan, Y. Liu et al., Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study, PLOS ONE, vol.14, issue.2, p.153524, 2016.
DOI : 10.1371/journal.pone.0153524.s003

T. Birrenbach and U. Böcker, Inflammatory Bowel Disease and Smoking, Inflammatory Bowel Diseases, vol.10, issue.6, pp.848-59, 2004.
DOI : 10.1097/00054725-200411000-00019

J. Cosnes, Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice, Best Practice & Research Clinical Gastroenterology, vol.18, issue.3, pp.481-96, 2004.
DOI : 10.1016/j.bpg.2003.12.003

M. Aldhous, H. Drummond, N. Anderson, R. Baneshi, M. Smith et al., Smoking Habit and Load Influence Age at Diagnosis and Disease Extent in Ulcerative Colitis, The American Journal of Gastroenterology, vol.63, issue.3, pp.589-97, 2007.
DOI : 10.1038/nri803

P. Lakatos, Smoking in inflammatory bowel diseases: Good, bad or ugly?, World Journal of Gastroenterology, vol.13, issue.46, p.6134, 2007.
DOI : 10.3748/wjg.13.6134

R. Luo, L. Huo, J. Zhang, and Q. Zhang, [Meta-analysis on causes of ulcerative colitis], Zhonghua Liu Xing Bing Xue Za Zhi Zhonghua Liuxingbingxue Zazhi. déc, vol.36, issue.12, pp.1419-1442, 2015.

J. Cosnes, I. Nion-larmurier, P. Afchain, L. Beaugerie, and J. Gendre, Gender differences in the response of colitis to smoking, Clinical Gastroenterology and Hepatology, vol.2, issue.1, pp.41-49, 2004.
DOI : 10.1016/S1542-3565(03)00290-8

J. Cosnes and P. Seksik, Environmental factors in Crohn???s disease, Acta Endoscopica, vol.349, issue.5, pp.679-88, 2006.
DOI : 10.1097/00054725-199905000-00006

M. Sopori, Science and society: Effects of cigarette smoke on the immune system, Nature Reviews Immunology, vol.100, issue.5, pp.372-379, 2002.
DOI : 10.1016/S0006-2952(99)00122-7

Y. Arnson, Y. Shoenfeld, and H. Amital, Effects of tobacco smoke on immunity, inflammation and autoimmunity, Journal of Autoimmunity, vol.34, issue.3, pp.258-65, 2010.
DOI : 10.1016/j.jaut.2009.12.003

R. Gonçalves, R. Coletta, K. Silvério, L. Benevides, M. Casati et al., Impact of smoking on inflammation: overview of molecular mechanisms, Inflammation Research, vol.14, issue.5, pp.409-433, 2011.
DOI : 10.1159/000107058

O. Rom, K. Avezov, D. Aizenbud, and A. Reznick, Cigarette smoking and inflammation revisited, Respiratory Physiology & Neurobiology, vol.187, issue.1, pp.5-10, 2013.
DOI : 10.1016/j.resp.2013.01.013

S. Verschuere, D. Smet, R. Allais, L. Cuvelier, and C. , The effect of smoking on intestinal inflammation: What can be learned from animal models?, Journal of Crohn's and Colitis, vol.6, issue.1, pp.1-12, 2012.
DOI : 10.1016/j.crohns.2011.09.006

X. Guo, E. Liu, J. Ko, B. Wong, Y. Ye et al., Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats, European Journal of Pharmacology, vol.411, issue.1-2, pp.193-203, 2001.
DOI : 10.1016/S0014-2999(00)00914-6

V. Galitovskiy, J. Qian, A. Chernyavsky, S. Marchenko, V. Gindi et al., Cytokine-Induced Alterations of ??7 Nicotinic Receptor in Colonic CD4 T Cells Mediate Dichotomous Response to Nicotine in Murine Models of Th1/Th17- versus Th2-Mediated Colitis, The Journal of Immunology, vol.187, issue.5, pp.2677-87, 2011.
DOI : 10.4049/jimmunol.1002711

G. Parkes, K. Whelan, and J. Lindsay, Smoking in inflammatory bowel disease: Impact on disease course and insights into the aetiology of its effect, Journal of Crohn's and Colitis, vol.8, issue.8, pp.717-742, 2014.
DOI : 10.1016/j.crohns.2014.02.002

S. Bridger, J. Lee, I. Bjarnason, J. Jones, and A. Macpherson, In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn's disease and non-smokers develop ulcerative colitis, Gut, vol.51, issue.1, pp.21-26, 2002.
DOI : 10.1136/gut.51.1.21

E. Lindberg, G. Järnerot, and B. Huitfeldt, Smoking in Crohn's disease: effect on localisation and clinical course., Gut, vol.33, issue.6, pp.779-82, 1992.
DOI : 10.1136/gut.33.6.779

M. Bustamante, P. Nos, M. Hoyos, J. Hinojosa, J. Molés et al., Relationship between smoking and colonic involvement in inflammatory bowel disease. Rev Esp Enfermedades Dig Organo Of Soc Esp Patol Dig, déc, vol.90, issue.12, pp.833-873, 1998.

A. Karban, Effect of smoking on inflammatory bowel disease: Is it disease or organ specific, World Journal of Gastroenterology, vol.13, issue.15, p.2150, 2007.
DOI : 10.3748/wjg.v13.i15.2150

M. Aldhous, K. Soo, L. Stark, A. Ulanicka, J. Easterbrook et al., Cigarette Smoke Extract (CSE) Delays NOD2 Expression and Affects NOD2/RIPK2 Interactions in Intestinal Epithelial Cells, PLoS ONE, vol.15, issue.9, p.24715, 2011.
DOI : 10.1371/journal.pone.0024715.g008

S. Wei, Y. Tan, M. Weng, L. Lai, J. Hsiao et al., SLCO3A1, a Novel Crohn???s Disease-Associated Gene, Regulates NF-??B Activity and Associates with Intestinal Perforation, PLoS ONE, vol.4, issue.6, p.100515, 2014.
DOI : 10.1371/journal.pone.0100515.t004

R. Arsenescu, V. Arsenescu, J. Zhong, M. Nasser, R. Melinte et al., Role of the xenobiotic receptor in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.17, issue.5, pp.1149-62, 2011.
DOI : 10.1002/ibd.21463

I. Monteleone, F. Pallone, and G. Monteleone, Aryl hydrocarbon receptor and colitis, Seminars in Immunopathology, vol.491, issue.7423, pp.671-676, 2013.
DOI : 10.1038/nature11535

J. Benjamin, C. Hedin, A. Koutsoumpas, S. Ng, N. Mccarthy et al., Smokers with active Crohn??s disease have a clinically relevant dysbiosis of the gastrointestinal microbiota*, Inflammatory Bowel Diseases, vol.18, issue.6, pp.1092-100, 2012.
DOI : 10.1002/ibd.21864

O. Nielsen, J. Bjerrum, C. Csillag, F. Nielsen, and J. Olsen, Influence of Smoking on Colonic Gene Expression Profile in Crohn's Disease, PLoS ONE, vol.4, issue.7, p.6210, 2009.
DOI : 10.1371/journal.pone.0006210.t002

A. Wakefield, A. Sawyerr, A. Dhillon, R. Pittilo, P. Rowles et al., PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTION, The Lancet, vol.334, issue.8671, pp.1057-62, 1989.
DOI : 10.1016/S0140-6736(89)91078-7

J. Cosnes, Tabac et maladies inflammatoires chroniques de l'intestin. Hépato-Gastro Oncol Dig. 1 févr, pp.33-41, 2000.

A. Wakefield, A. Sawyerr, M. Hudson, A. Dhillon, and R. Pounder, Smoking, the oral contraceptive pill, and Crohn's disease, Digestive Diseases and Sciences, vol.97, issue.8, pp.1147-50, 1991.
DOI : 10.1007/BF01297463

X. Guo, W. Wang, J. Ko, and C. Cho, Involvement of neutrophils and free radicals in the potentiating effects of passive cigarette smoking on inflammatory bowel disease in rats, Gastroenterology, vol.117, issue.4, pp.884-92, 1999.
DOI : 10.1016/S0016-5085(99)70347-1

M. Pelissier-rota, L. Pelosi, P. Meresse, and M. Jacquier-sarlin, Nicotine-induced cellular stresses and autophagy in human cancer colon cells: A supportive effect on cell homeostasis via up-regulation of Cox-2 and PGE2 production, The International Journal of Biochemistry & Cell Biology, vol.65, pp.239-56, 2015.
DOI : 10.1016/j.biocel.2015.06.013

G. Thomas, J. Rhodes, and J. Ingram, Mechanisms of Disease: nicotine???a review of its actions in the context of gastrointestinal disease, Nature Clinical Practice Gastroenterology & Hepatology, vol.308, issue.11, pp.536-580, 2005.
DOI : 10.1038/89961

G. Bastida and B. Beltrán, Ulcerative colitis in smokers, non-smokers and ex-smokers, World Journal of Gastroenterology, vol.17, issue.22, p.2740, 2011.
DOI : 10.3748/wjg.v17.i22.2740

J. Birtwistle, The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis., Postgraduate Medical Journal, vol.72, issue.854, pp.714-722, 1996.
DOI : 10.1136/pgmj.72.854.714

P. Suenaert, V. Bulteel, D. Hond, E. Hiele, M. Peeters et al., The effects of smoking and indomethacin on small intestinal permeability, Alimentary Pharmacology and Therapeutics, vol.32, issue.6, pp.819-841, 2000.
DOI : 10.1016/0016-5085(94)90138-4

G. Thomas, Role of smoking in inflammatory bowel disease: implications for therapy, Postgraduate Medical Journal, vol.76, issue.895, pp.273-282, 2000.
DOI : 10.1136/pmj.76.895.273

J. Green, C. Richardson, R. Marshall, J. Rhodes, H. Mckirdy et al., Nitric oxide mediates a therapeutic effect of nicotine in ulcerative colitis, Alimentary Pharmacology and Therapeutics, vol.109, issue.11, pp.1429-1463, 2000.
DOI : 10.1007/s002689900354

Y. Ding, Y. Ladeiro, I. Morilla, Y. Bouhnik, A. Marah et al., Integrative networkbased analysis of colonic detoxification gene expression in Ulcerative Colitis according to smoking status, J Crohns Colitis, vol.11, issue.4, pp.474-84, 2017.

X. Tréton, E. Pedruzzi, C. Guichard, Y. Ladeiro, S. Sedghi et al., Combined NADPH Oxidase 1 and Interleukin 10 Deficiency Induces Chronic Endoplasmic Reticulum Stress and Causes Ulcerative Colitis-Like Disease in Mice, PLoS ONE, vol.2011, issue.7, p.101669, 2014.
DOI : 10.1371/journal.pone.0101669.s012

Y. Ding, Etude de l'implication du système de détoxification des xénobiotiques dans la rectocolite hémorragique, Thèse confidentielle jusqu'au 28 Octobre 2017. Citation autorisée par les auteurs, 2015.

M. Russel, F. Nieman, J. Bergers, and R. Stockbrügger, Cigarette smoking and quality of life in patients with inflammatory bowel disease, European Journal of Gastroenterology & Hepatology, vol.8, issue.11, pp.1075-81, 1996.
DOI : 10.1097/00042737-199611000-00009

J. Cosnes, F. Carbonnel, L. Beaugerie, L. Quintrec, Y. Gendre et al., Effects of cigarette smoking on the long-term course of Crohn's disease, Gastroenterology, vol.110, issue.2, pp.424-455, 1996.
DOI : 10.1053/gast.1996.v110.pm8566589

T. Nunes, M. Etchevers, E. Domènech, V. García-sánchez, Y. Ber et al., Smoking does influence disease behaviour and impacts the need for therapy in Crohn???s disease in the biologic era, Alimentary Pharmacology & Therapeutics, vol.61, issue.Suppl. A, pp.752-60, 2013.
DOI : 10.1136/gutjnl-2011-301971

T. Nunes, M. Etchevers, V. García-sánchez, D. Ginard, E. Martí et al., Impact of Smoking Cessation on the Clinical Course of Crohn???s Disease Under Current Therapeutic Algorithms: A Multicenter Prospective Study, The American Journal of Gastroenterology, vol.110, issue.3, pp.411-420, 2016.
DOI : 10.1038/ajg.2014.300

G. Johnson, J. Cosnes, and J. Mansfield, Review article: smoking cessation as primary therapy to modify the course of Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.121, issue.5, pp.921-952, 2005.
DOI : 10.1001/archpsyc.55.8.683

J. Cosnes, L. Beaugerie, F. Carbonnel, and J. Gendre, Smoking cessation and the course of Crohn's disease: An intervention study, Gastroenterology, vol.120, issue.5, pp.1093-1102, 2001.
DOI : 10.1053/gast.2001.23231

N. To, D. Gracie, and A. Ford, Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease, Alimentary Pharmacology & Therapeutics, vol.110, issue.5, pp.549-61, 2016.
DOI : 10.1038/ajg.2014.300

P. Lunney and R. Leong, Review article: ulcerative colitis, smoking and nicotine therapy, Alimentary Pharmacology & Therapeutics, vol.37, issue.11-12, pp.997-1008, 2012.
DOI : 10.1016/j.dld.2005.05.010

M. Mokbel, F. Carbonnel, L. Beaugerie, J. Gendre, and J. Cosnes, Effet du tabac sur l'évolution à long terme de la rectocolite hémorragique, Gastroentérologie Clin Biol. nov, vol.22, issue.11, pp.858-62, 1998.

L. Beaugerie, N. Massot, F. Carbonnel, S. Cattan, J. Gendre et al., Impact of cessation of smoking on the course of ulcerative colitis, The American Journal of Gastroenterology, vol.42, issue.7, pp.2113-2119, 2001.
DOI : 10.1111/j.1572-0241.2001.03944.x

L. Higuchi, H. Khalili, A. Chan, J. Richter, A. Bousvaros et al., A Prospective Study of Cigarette Smoking and the Risk of Inflammatory Bowel Disease in Women, The American Journal of Gastroenterology, vol.135, issue.9, pp.1399-406, 2012.
DOI : 10.1093/jnci/89.13.948

N. To, A. Ford, and D. Gracie, Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis, Alimentary Pharmacology & Therapeutics, vol.6, issue.4, pp.117-143, 2016.
DOI : 10.1016/j.crohns.2012.09.002

T. Chivese, T. Esterhuizen, and A. Basson, The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn???s Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa, PLOS ONE, vol.103, issue.9, p.139597, 2015.
DOI : 10.1371/journal.pone.0139597.s002

B. Lashner, N. Shaheen, S. Hanauer, and B. Kirschner, Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children, Am J Gastroenterol. mars, vol.88, issue.3, pp.356-365, 1993.

D. Jones, M. Osterman, M. Bewtra, and J. Lewis, Passive Smoking and Inflammatory Bowel Disease: A Meta-Analysis, The American Journal of Gastroenterology, vol.29, issue.9, pp.2382-93, 2008.
DOI : 10.1016/S0025-6196(12)61637-1

F. Van-der-heide, A. Dijkstra, R. Weersma, F. Albersnagel, E. Van-der-logt et al., Effects of active and passive smoking on disease course of Crohn??s disease and ulcerative colitis, Inflammatory Bowel Diseases, vol.15, issue.8, pp.1199-207, 2009.
DOI : 10.1002/ibd.20884

. Vidal, Les médicaments de la maladie de Crohn -EurekaSanté par VIDAL [Internet], Disponible sur, 2017.

P. Dalibon, Maladie de Crohn et rectocolite ulc??ro-h??morragique, de grandes similitudes, Actualit??s Pharmaceutiques, vol.54, issue.545, pp.20-24, 2015.
DOI : 10.1016/j.actpha.2015.02.005

P. Dalibon, Comment prendre en charge une maladie inflammatoire chronique de l???intestin???, Actualit??s Pharmaceutiques, vol.54, issue.545, pp.25-32, 2015.
DOI : 10.1016/j.actpha.2015.02.006

C. Klotz, M. Barret, M. Dhooge, A. Oudjit, S. Chaussade et al., Rectocolite h??morragique??: conduite diagnostique et prise en charge th??rapeutique, La Presse M??dicale, vol.44, issue.2, pp.144-153, 2015.
DOI : 10.1016/j.lpm.2014.06.025

J. Mcgrath, J. Mcdonald, and J. Macdonald, Transdermal nicotine for induction of remission in ulcerative colitis, Disponible sur, 2004.
DOI : 10.7326/0003-4819-126-5-199703010-00004

S. Nikfar, S. Ehteshami-ashar, R. Rahimi, and M. Abdollahi, Systematic Review and Meta-Analysis of the Efficacy and Tolerability of Nicotine Preparations in Active Ulcerative Colitis, Clinical Therapeutics, vol.32, issue.14, pp.2304-2319, 2010.
DOI : 10.1016/j.clinthera.2011.01.004

P. Shields and T. Low-beer, Patients' awareness of adverse relation between Crohn's disease and their smoking: questionnaire survey, BMJ, vol.313, issue.7052, p.265, 1996.
DOI : 10.1136/bmj.313.7052.265

W. Ryan, C. Ley, R. Allan, and M. Keighley, Patients With Crohn's Disease Are Unaware of the Risks That Smoking Has on Their Disease, Journal of Gastrointestinal Surgery, vol.7, issue.5, pp.706-717, 2003.
DOI : 10.1016/S1091-255X(03)00066-0

C. De-bie, V. Ballet, N. Hendriks, S. Coenen, E. Weyts et al., Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, vol.7, issue.Suppl. 2, pp.1294-302, 2015.
DOI : 10.1016/j.crohns.2012.08.019

N. Saadoune, L. Peyrin-biroulet, C. Baumann, M. Bigard, N. Wirth et al., Beliefs and behaviour about smoking among inflammatory bowel disease patients, European Journal of Gastroenterology & Hepatology, vol.27, issue.7, pp.797-803, 2015.
DOI : 10.1097/MEG.0000000000000371

R. Hilsden, D. Hodgins, D. Czechowsky, M. Verhoef, and L. Sutherland, Attitudes toward smoking and smoking behaviors of patients with crohn's disease, The American Journal of Gastroenterology, vol.5, issue.6, pp.1849-53, 2001.
DOI : 10.1111/j.1572-0241.2000.t01-1-01789.x

F. Van-der-heide, A. Dijkstra, F. Albersnagel, J. Kleibeuker, and G. Dijkstra, Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis, Journal of Crohn's and Colitis, vol.4, issue.2, pp.125-156, 2010.
DOI : 10.1016/j.crohns.2009.09.005

T. Nunes, M. Etchevers, O. Merino, S. Gallego, V. García-sánchez et al., High smoking cessation rate in Crohn's disease patients after physician advice ??? The TABACROHN Study, Journal of Crohn's and Colitis, vol.7, issue.3, pp.202-209, 2013.
DOI : 10.1016/j.crohns.2012.04.011

Y. Leung, G. Kaplan, K. Rioux, J. Hubbard, S. Kamhawi et al., Assessment of Variables Associated with Smoking Cessation in Crohn???s Disease, Digestive Diseases and Sciences, vol.70, issue.4, pp.1026-1058, 2012.
DOI : 10.1016/j.pec.2007.10.005

G. Hollands, S. Whitwell, R. Parker, N. Prescott, A. Forbes et al., Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial, BMJ, vol.345, issue.jul20 1, p.4708, 2012.
DOI : 10.1136/bmj.e4708

S. Coward, S. Heitman, F. Clement, M. Negron, R. Panaccione et al., Funding a Smoking Cessation Program for Crohn???s Disease: An Economic Evaluation, The American Journal of Gastroenterology, vol.5, issue.3, pp.368-77, 2015.
DOI : 10.1176/appi.ajp.2013.12121599

C. Peyrin-biroulet, N. Wirth, L. Peyrin-biroulet, and Y. Martinet, Sevrage tabagique et MICI: comment s'y prendre ? Lett Hépato-Gastroentérologue, pp.193-198, 2012.

G. Lagrue and P. Dupont, Sevrage tabagique : comment prévenir les rechutes, Rev Prat Médecine Générale, issue.635, pp.1701-1705, 2003.

R. Hilsden, D. Hodgins, A. Timmer, and L. Sutherland, Clinical Reviews. Helping patients with Crohn's disease quit smoking, The American Journal of Gastroenterology, vol.39, issue.2, pp.352-360, 2000.
DOI : 10.1056/NEJM199903043400903

C. Chevalier, A. Nguyen, I. Nougier, and P. Villéger, Accompagner l???arr??t du tabac, Actualit??s Pharmaceutiques, vol.54, issue.544, pp.6-11, 2015.
DOI : 10.1016/j.actpha.2014.12.005

D. Rubin, S. Friedman, and F. Farraye, MICI: 49 questions cliniques incontournables, 2016.

S. Faure, M. Babin, H. Velé, G. Dubé, M. Samson et al., La prise en charge de la d??pendance au tabac, Actualit??s Pharmaceutiques, vol.53, issue.535, pp.27-30, 2014.
DOI : 10.1016/j.actpha.2014.02.006

C. Peyrin-biroulet, N. Wirth, and Y. Martinet, Mieux prendre en charge le tabagisme : il est urgent d'agir. HEGEL -HEpato-GastroEntérologie Libérale Disponible sur, p.53783, 2042.

A. Dansou, C. Pousséo, V. Kaniut, A. Leloup, M. Aubry et al., L'aide au sevrage tabagique dans les officines françaises, pp.167-76, 2015.